MYC and cancer: These results are similar to those of Nicklas et al. [42] where c-Myc expression is controlled by E3 ligase TRIM32 and deubiquitinase USP7, and the net balance between protein ubiquitination and deubiquitination acts as a key determinant for cancer development.